Obesity and osteoarthritis: Can weight loss drugs help beyond the scales?

Osteoarthritis is one of the most common causes of joint pain, usually described as a simple result of “wear and tear” as we age. But new research is changing that view.

In this webinar, we’ll explore how osteoarthritis is now understood as an inflammatory condition, and why obesity plays a much bigger role than simply putting extra strain on joints. You’ll learn how inflammation links body weight and joint health in ways we didn’t fully appreciate before.

The talk will also look at the much‑discussed new weight‑loss drugs, such as Mounjaro. We’ll explain what these medicines are, how they work, and why they have attracted so much attention because of the significant weight‑loss seen in clinical trials. Importantly, we’ll discuss emerging evidence that some people with osteoarthritis who are taking these drugs are also experiencing improvements in joint pain and symptoms.

Finally, we’ll share exciting new research, which is investigating whether these drugs might help joints directly – not just by reducing body weight, but by calming inflammation inside the joint itself.

No science background is needed – register now!

Our expert

This webinar will be presented by Simon Jones, Professor in Musculoskeletal Ageing at the University of Birmingham and lead for the National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre’s Sarcopenia and Multimorbidity research theme.